(PX) P10 - Overview
Stock: Private Equity, Venture Capital, Impact Investing, Private Credit
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.34% |
| Yield on Cost 5y | 1.29% |
| Yield CAGR 5y | 18.30% |
| Payout Consistency | 100.0% |
| Payout Ratio | 26.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 44.7% |
| Relative Tail Risk | -2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.59 |
| Alpha | -44.41 |
| Character TTM | |
|---|---|
| Beta | 1.337 |
| Beta Downside | 1.629 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.16% |
| CAGR/Max DD | -0.05 |
Description: PX P10 January 15, 2026
P10 Inc. (NYSE: PX) is a Dallas-based, publicly traded private-market solutions provider that operates in the United States and Dubai. Founded in 1992, the firm offers a suite of alternative-asset services spanning private equity, venture capital, impact investing, and private credit, delivered through a network of branded platforms.
The company’s private-equity franchise is marketed under RCP Advisors, Bonaccord Capital, and P10 Advisors; its venture-capital offering is sold as TrueBridge; impact-investment solutions are branded Enhanced; and private-credit products are offered via Five Points, Hark Capital, and WTI. This multi-brand structure allows P10 to target distinct investor segments while cross-selling secondary-market and co-investment opportunities.
Industry data suggests that total U.S. private-market assets under management (AUM) reached roughly $12 trillion in 2023, growing at ~9 % YoY, driven by continued capital inflows into private equity and credit despite a tightening monetary environment. P10’s latest 10-K disclosed estimated AUM of about $2.5 billion, with private-credit assets expanding faster than its equity platform-a trend consistent with investors seeking higher yields as interest rates remain elevated. The firm’s revenue mix is roughly 55 % fee-based and 45 % performance-related, indicating exposure to both market cycles and fund-level performance.
For a deeper, data-driven look at how P10’s valuation stacks up against sector peers, the ValueRay platform offers a transparent, metric-focused analysis worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 15.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.87 > 1.0 |
| NWC/Revenue: 9.83% < 20% (prev 43.54%; Δ -33.71% < -1%) |
| CFO/TA 0.03 > 3% & CFO 27.8m > Net Income 15.3m |
| Net Debt (384.1m) to EBITDA (74.9m): 5.12 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.8m) vs 12m ago -1.24% < -2% |
| Gross Margin: 49.90% > 18% (prev 0.43%; Δ 4946 % > 0.5%) |
| Asset Turnover: 33.61% > 50% (prev 32.03%; Δ 1.58% > 0%) |
| Interest Coverage Ratio: 1.82 > 6 (EBITDA TTM 74.9m / Interest Expense TTM 27.1m) |
Altman Z'' -0.52
| A: 0.03 (Total Current Assets 166.3m - Total Current Liabilities 136.7m) / Total Assets 936.0m |
| B: -0.22 (Retained Earnings -204.3m / Total Assets 936.0m) |
| C: 0.06 (EBIT TTM 49.4m / Avg Total Assets 896.5m) |
| D: -0.37 (Book Value of Equity -200.1m / Total Liabilities 539.2m) |
| Altman-Z'' Score: -0.52 = B |
Beneish M -3.03
| DSRI: 1.07 (Receivables 125.5m/107.3m, Revenue 301.3m/274.5m) |
| GMI: 0.86 (GM 49.90% / 43.15%) |
| AQI: 1.02 (AQ_t 0.79 / AQ_t-1 0.77) |
| SGI: 1.10 (Revenue 301.3m / 274.5m) |
| TATA: -0.01 (NI 15.3m - CFO 27.8m) / TA 936.0m) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of PX shares?
Over the past week, the price has changed by -5.38%, over one month by -3.32%, over three months by -1.43% and over the past year by -23.87%.
Is PX a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.9 | 55.7% |
| Analysts Target Price | 15.9 | 55.7% |
| ValueRay Target Price | 10.1 | -0.8% |
PX Fundamental Data Overview February 03, 2026
P/E Forward = 10.0
P/S = 3.936
P/B = 3.4781
Revenue TTM = 301.3m USD
EBIT TTM = 49.4m USD
EBITDA TTM = 74.9m USD
Long Term Debt = 323.5m USD (from longTermDebt, last quarter)
Short Term Debt = 69.9m USD (from shortTermDebt, last quarter)
Debt = 424.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 384.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.47b USD (1.09b + Debt 424.1m - CCE 40.0m)
Interest Coverage Ratio = 1.82 (Ebit TTM 49.4m / Interest Expense TTM 27.1m)
EV/FCF = 64.96x (Enterprise Value 1.47b / FCF TTM 22.6m)
FCF Yield = 1.54% (FCF TTM 22.6m / Enterprise Value 1.47b)
FCF Margin = 7.52% (FCF TTM 22.6m / Revenue TTM 301.3m)
Net Margin = 5.09% (Net Income TTM 15.3m / Revenue TTM 301.3m)
Gross Margin = 49.90% ((Revenue TTM 301.3m - Cost of Revenue TTM 151.0m) / Revenue TTM)
Gross Margin QoQ = 44.26% (prev 55.79%)
Tobins Q-Ratio = 1.57 (Enterprise Value 1.47b / Total Assets 936.0m)
Interest Expense / Debt = 1.65% (Interest Expense 6.99m / Debt 424.1m)
Taxrate = 25.73% (1.05m / 4.08m)
NOPAT = 36.7m (EBIT 49.4m * (1 - 25.73%))
Current Ratio = 1.22 (Total Current Assets 166.3m / Total Current Liabilities 136.7m)
Debt / Equity = 1.23 (Debt 424.1m / totalStockholderEquity, last quarter 344.8m)
Debt / EBITDA = 5.12 (Net Debt 384.1m / EBITDA 74.9m)
Debt / FCF = 16.96 (Net Debt 384.1m / FCF TTM 22.6m)
Total Stockholder Equity = 340.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.71% (Net Income 15.3m / Total Assets 936.0m)
RoE = 4.50% (Net Income TTM 15.3m / Total Stockholder Equity 340.9m)
RoCE = 7.44% (EBIT 49.4m / Capital Employed (Equity 340.9m + L.T.Debt 323.5m))
RoIC = 5.23% (NOPAT 36.7m / Invested Capital 701.8m)
WACC = 8.14% (E(1.09b)/V(1.51b) * Re(10.84%) + D(424.1m)/V(1.51b) * Rd(1.65%) * (1-Tc(0.26)))
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.64%
[DCF Debug] Terminal Value 79.56% ; FCFF base≈42.0m ; Y1≈48.4m ; Y5≈68.1m
Fair Price DCF = 9.63 (EV 1.14b - Net Debt 384.1m = Equity 751.5m / Shares 78.1m; r=8.14% [WACC]; 5y FCF grow 17.89% → 2.90% )
EPS Correlation: -44.79 | EPS CAGR: -45.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 92.65 | Revenue CAGR: 14.54% | SUE: -0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.24 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.09 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+21.0% | Growth Revenue=+18.9%